NEW YORK (GenomeWeb) – NeoGenomics has filed with the US Securities and Exchange Commission for a public offering of approximately $150 million of its common stock, the firm said after the close of the market on Monday.
The company, based in Fort Myers, Florida, said that it plans to use the net proceeds from the offering for general corporate purposes.
In addition to the $150 million offering, NeoGenomics will grant the underwriters a 30-day option to purchase up to an additional $22.5 million worth of common stock at the public offering price, less underwriting discounts and commissions.
Morgan Stanley, SVB Leerink, and William Blair are representatives of the underwriters and book-running managers for the offering. Cantor Fitzgerald, Craig-Hallum Capital Group, and Needham & Company are co-managers for the offering.